Preview

Russian Journal of Cardiology

Advanced search

Transcatheter “valve-in-valve” implantation of bioprosthesis in failed surgical tricuspid bioprosthesis (first experience in Russia)

https://doi.org/10.15829/1560-4071-2019-2-31-37

Abstract

Aim. In the issue we report first in Russia experience of transcatheter “valve-invalve” implantation (TVIV) for treatment of severe tricuspid stenosis due to the structural deterioration of surgical tricuspid bioprosthesis.

Material and methods. TVIV was performed in 4 high-risk redo patients (1 to 3 previous sternotomies) of various ages across (18-68 years) with structural deterioration of surgical tricuspid bioprosthesis.

Results. Technical success was achieved in 100% cases. Diastolic gradients on tricuspid valve markedly decreased in all patients. Peak transtricuspidal gradient decreased from 20,4 to 10 mmHg in average. Clinical improvement as assessed by 6-minute walk test after TVIV was observed in 3 patients with congestive heart failure. In 1 patient with asymptomatic right ventricle dysfunction TVIV resulted in the enhancement of echocardiographic parameters.

Conclusion. TVIV is a mininvasive alternative to conventional surgical tricuspid valve redo replacement. Based on available data including own experience TVIV should be considered an effective and safe treatment option for failed TV bioprostheses in high-risk patients of different age. Further studies are needed to assess long-term results of the method.

About the Authors

T. E. Imaev
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: Imaev T. E. is a clinical specialist at Edwards Lifescience, Medtronic


A. E. Komlev
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


V. V. Romakina
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


P. M. Lepilin
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


M. I. Makeev
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


A. S. Kolegaev
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


A. A. Margolina
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


O. V. Sapelnikov
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


I. S. Fedotenkov
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


M. A. Saidova
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


R. S. Akchurin
National Medical Research Center of Cardiology
Russian Federation

Moscow


Competing Interests: no conflict of interest to declare


References

1. Dvir D, Webb JG, Bleiziffer S, et al. Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312:162-70. doi:10.1001/jama.20147246.

2. Imaev TE, Komlev AE, Kolegaev AS, et al. Current state of the problem of transcatheter valve-in-valve replacement. Consilium Medicum. 2016;05:89-92. (In Russ.)

3. Laule M, Stangl V, Sanad W, et al. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol. 2013;61:1929-31. doi:10.1016/j.jacc.2013.01.070.

4. Roberts PA, Boudjemline Y, Cheatham JP, et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol.2011;58:117-22. doi:10.1016/j.jacc.2011.01.044.

5. McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter Tricuspid Valve-inValve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study. Circulation. 2016 Apr 19;133(16):1582-93. doi:10.1161/CIRCULATIONAHA.115.019353.

6. Jeganathan R, Armstrong S, Al-Alao B, et al. The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg. 2013;95:119-24. doi:10.1016/j.athoracsur.2012.08.058.

7. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012; 42:1-44. doi:10.1093/ejcts/ezs455.

8. Ahmad Y, Demir O, Rajkumar C, et al. Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis. Open Heart. 2018;5:e000748. doi:10.1136/openhrt-2017-000748.

9. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-91. doi:10.1093/eurheartj/ehx391.

10. Bockeria LA, Gudkova RG, Milievskaya EB, et al. Cardiovascular surgery — 2016. Diseases and congenital anomalies of the circulatory system. M.: A. N. Bakoulev Scientific Center for Cardiovascular Surgery. 2017. рр. 57-65. (In Russ.) ISBN 978-5-7982-0382-6.

11. Hanedan MO, Cicekcioglu F, Aksoyek A, et al. Tricuspid Valve Replacement Through Right Thoracotomy has Better Outcomes in Redo Cases. Heart, Lung and Circulation. 2017;26:88-93. doi:10.1016/j.hlc.2016.05.118.

12. Vahl TP, Hahn RT, Moses JW, et al. Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid Valves: Completing the Quest. Circulation. 2016;133(16):1537-9. doi:10.1161/CIRCULATIONAHA.116.022160.

13. Bapat V, Mydin I, Chadalavada S, et al. A guide to fluoroscopic identification and design of bioprosthetic valves: a reference for valve-in-valve procedure. Catheter Cardiovasc Interv. 2013;81:853-61. doi:10.1002/ccd.24419.

14. Bapat V. Technical pitfalls and tips for the valve-in-valve procedure. Annals of Cardiothoracic Surgery. 2017;6(5):541-52. doi:10.21037/acs.2017.09.13.

15. Taggart NW, Cabalka AK. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. Am J Cardiol. 2018 Jan 15;121(2):262-8. doi:10.1016/j.amjcard.2017.10.017.


Review

For citations:


Imaev T.E., Komlev A.E., Romakina V.V., Lepilin P.M., Makeev M.I., Kolegaev A.S., Margolina A.A., Sapelnikov O.V., Fedotenkov I.S., Saidova M.A., Akchurin R.S. Transcatheter “valve-in-valve” implantation of bioprosthesis in failed surgical tricuspid bioprosthesis (first experience in Russia). Russian Journal of Cardiology. 2019;(2):31-37. (In Russ.) https://doi.org/10.15829/1560-4071-2019-2-31-37

Views: 936


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)